A comprehensive study of circulating tumour cells at the moment of prostate cancer diagnosis: biological and clinical implications of EGFR, AR and SNPs

Abstract

Circulating tumor cells (CTCs) have been recently accepted as prognostic markers in metastatic prostate cancer (PCa). However, very few studies have analyzed their role in early-stage PCa. The aim of this research is to study the value of CTCs at the moment of PCa diagnosis and to identify different subpopulations of CTCs. Patients with PSA value > 4 ng/ml and clinical suspicion of PCa were included. Samples were collected immediately before prostatic biopsy. CTCs were isolated by immunomagnetic technique using a multi-CK specific antibody. Molecular expression of EGFR and AR in the tissue was analysed by real-time PCR. Up to eight different SNPs in patients' blood DNA were studied. In a total of 86 patients, the CTC detection rate was 18.6%. The sensitivity, specificity, positive and negative predictive values of CTCs to detect PCa was 14.2%, 78.4%, 31.2% and 57.4%, respectively. Up to 75% of CTC-positive patients were AR-negative. A direct association was found between the expression of AR in the prostatic tissue and the presence of CTCs in blood (p<0.05). We observed an inverse relation between the expression of EGFR in the tissue and the expression of AR in the CTCs. No significant association between SNPs and CTCs was found. The low detection rate of CTCs in early-stage PCa limits their role as a diagnostic marker. Nevertheless, we show that they may hide important prognostic information. Overexpression of AR in the prostate may facilitate cell dissemination.

DOI: 10.18632/oncotarget.19718

6 Figures and Tables

Cite this paper

@inproceedings{PucheSanz2017ACS, title={A comprehensive study of circulating tumour cells at the moment of prostate cancer diagnosis: biological and clinical implications of EGFR, AR and SNPs}, author={Ignacio Puche-Sanz and Maria Jesus Alvarez-Cubero and Manrique Pascual-Geler and Alba Rodr{\'i}guez-Mart{\'i}nez and Miguel Delgado-Rodr{\'i}guez and Jos{\'e} Luis Garc{\'i}a-Puche and Jos{\'e} Angel Exp{\'o}sito and Inmaculada Robles-Fernandez and Carmen Entrala-Bernal and Jos{\'e} {\'A}ngel Lorente and Jos{\'e} Manuel C{\'o}zar-Olmo and Mar{\'i}a Serrano}, booktitle={Oncotarget}, year={2017} }